| Primary |
| Hormone Replacement Therapy |
21.8% |
| Menopausal Symptoms |
21.0% |
| Drug Use For Unknown Indication |
16.6% |
| Menopause |
9.6% |
| Hot Flush |
7.7% |
| Hypertension |
4.8% |
| Depression |
3.5% |
| Blood Cholesterol Increased |
2.3% |
| Hypothyroidism |
2.2% |
| Osteoporosis |
1.5% |
| Hysterectomy |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Rickets |
1.1% |
| Back Pain |
1.0% |
| Migraine |
0.8% |
| Thyroidectomy |
0.8% |
| Osteopenia |
0.7% |
| Anxiety |
0.7% |
| Osteoarthritis |
0.7% |
| Menopausal Symptoms Prophylaxis |
0.6% |
|
| Hot Flush |
16.4% |
| Application Site Rash |
12.8% |
| Pharmaceutical Product Complaint |
10.7% |
| Product Adhesion Issue |
10.5% |
| Product Quality Issue |
7.1% |
| Rash |
5.9% |
| No Adverse Event |
4.1% |
| Drug Ineffective |
3.6% |
| Application Site Pruritus |
3.1% |
| Headache |
3.1% |
| Application Site Irritation |
2.9% |
| Breast Cancer |
2.8% |
| Night Sweats |
2.5% |
| Weight Increased |
2.4% |
| Scar |
2.1% |
| Alopecia |
2.0% |
| Breast Cancer Female |
2.0% |
| Menopausal Symptoms |
2.0% |
| Pruritus |
2.0% |
| Application Site Erythema |
1.9% |
|
| Secondary |
| Hormone Replacement Therapy |
63.2% |
| Menopause |
13.2% |
| Menopausal Symptoms |
5.6% |
| Hot Flush |
3.6% |
| Night Sweats |
1.9% |
| Drug Use For Unknown Indication |
1.4% |
| Hypertension |
1.4% |
| Oestrogen Replacement Therapy |
1.2% |
| Product Used For Unknown Indication |
1.1% |
| Hormone Therapy |
0.9% |
| Depression |
0.9% |
| Osteoarthritis |
0.8% |
| Cough |
0.8% |
| Hysterectomy |
0.7% |
| Osteoporosis |
0.7% |
| Anxiety |
0.7% |
| Hypothyroidism |
0.6% |
| Increased Upper Airway Secretion |
0.5% |
| Blood Cholesterol Increased |
0.4% |
| Arthritis |
0.4% |
|
| Breast Cancer |
32.7% |
| Breast Cancer Female |
29.6% |
| Breast Cancer Metastatic |
5.9% |
| Hot Flush |
3.6% |
| Progesterone Receptor Assay Positive |
3.6% |
| Product Adhesion Issue |
3.4% |
| Contralateral Breast Cancer |
2.3% |
| Vomiting |
2.3% |
| Weight Decreased |
1.9% |
| Product Quality Issue |
1.7% |
| Vaginal Haemorrhage |
1.7% |
| Ovarian Cancer |
1.5% |
| Breast Cancer In Situ |
1.3% |
| Pharmaceutical Product Complaint |
1.3% |
| Scar |
1.3% |
| Dysphagia |
1.1% |
| Menopausal Symptoms |
1.1% |
| Ventricular Extrasystoles |
1.1% |
| Vulvovaginal Discomfort |
1.1% |
| Application Site Pruritus |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.3% |
| Osteoporosis |
8.3% |
| Hormone Replacement Therapy |
6.0% |
| Gastrooesophageal Reflux Disease |
5.6% |
| Pain |
5.3% |
| Drug Use For Unknown Indication |
4.4% |
| Hypertension |
3.6% |
| Depression |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Osteopenia |
2.8% |
| Menopause |
2.6% |
| Cardiac Disorder |
2.5% |
| Thyroid Disorder |
2.3% |
| Crohn's Disease |
2.2% |
| In Vitro Fertilisation |
2.2% |
| Blood Cholesterol |
2.1% |
| Anxiety |
1.9% |
| Fibromyalgia |
1.9% |
| Migraine |
1.9% |
| Blood Cholesterol Increased |
1.8% |
|
| Weight Increased |
14.7% |
| Weight Decreased |
13.2% |
| Vomiting |
10.0% |
| Urinary Tract Infection |
5.8% |
| Nausea |
5.3% |
| Drug Ineffective |
4.7% |
| Vision Blurred |
4.7% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Sinusitis |
3.7% |
| Thrombocytopenia |
3.7% |
| Urticaria |
3.7% |
| Uterine Prolapse |
3.7% |
| Nervousness |
3.2% |
| Pain |
3.2% |
| Paraesthesia |
3.2% |
| Colon Cancer Metastatic |
2.6% |
| Headache |
2.6% |
| Pain In Extremity |
2.6% |
| Pharmaceutical Product Complaint |
2.6% |
| Product Quality Issue |
2.6% |
|
